VCYT - Veracyte Inc logo

VCYT

Veracyte Inc

Veracyte, Inc. is a molecular diagnostics company that develops genomic tests for cancer diagnosis, including the Afirma classifier for thyroid cancer, Decipher classifiers for prostate and bladder cancers, and the Percepta test for lung cancer.

โš•๏ธ Healthcare NASDAQ Listed 2013 $ USD
$1,000 invested 10 years ago โ†’$8,848today

Score Overview

1 Year
Score
Net Growth72.54%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth8.65%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score8.2
Net Growth251.51%
Net Trend80%
Net Income Consistencyโ€”
Rev Growth155.97%
Rev TrendEvery year
Revenue Consistencyโ€”
10 Years
Score
Net Growth465.08%
Net Trend70%
Net Income Consistency
Rev Growth8x
Rev Trend90%
Revenue Consistency
All Time
Score
Net Growth6x
Net Trend62%
Net Income Consistency
Rev Growth25x
Rev Trend92%
Revenue Consistency

See the full market ranking โ†’

Veracyte Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 117M to $ 517M and net income went from -$ 34M to $ 66M. Revenue increased in every one of those 5 years; net income in 4.

Between 2015 and 2025, revenue grew from $ 49M to $ 517M and net income went from -$ 33M to $ 66M. Revenue increased in 9 of those 10 years; net income in 7.

Veracyte Inc currently holds a 5-year HDB Score of 8.2 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 44.68โ€”
1 Year2025-08-12
$ 28.7755.30%
5 Years2021-08-12
$ 42.525.08%
10 Years2016-08-12
$ 5.058x
All Time2013-10-30
$ 13.25237.21%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 561M$ 114M$ 485M
2025$ 517M$ 66M$ 412M
2024$ 445M$ 24M$ 289M
2023$ 361M-$ 74M$ 216M
2022$ 296M-$ 36M$ 178M
2021$ 219M-$ 75M$ 177M
2020$ 117M-$ 34M$ 349M
2019$ 120M-$ 12M$ 159M
2018$ 92M-$ 22M$ 77M
2017$ 71M-$ 31M$ 33M
2016$ 65M-$ 31M$ 59M
2015$ 49M-$ 33M$ 39M
2014$ 38M-$ 29M$ 35M
IPO2013$ 21M-$ 25M$ 71M

Explore beyond VCYT

You're looking at Veracyte Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies